Kent among universities to benefit from multi-million pound health and social care award

A £5.2 million package of renewed funding for health and social care researchers in the South East has ensured that they will receive valuable support and advice for the next five years.

Funded by the National Institute for Health Research (NIHR), the award will be made to the member universities of the NIHR Research Design Service South East (RDS South East). Formed in 2008 to increase the quality and quantity of successful grant applications from researchers, the organisation includes the universities of Kent, Brighton and Surrey. Its services are open and offered to individuals seeking funding for applied health and social care research from open national peer reviewed funding programmes.

Kent’s Centre for Health Services Studies (CHSS) works in collaboration with the Faculty of Health and Social Sciences at the University of Brighton and the Faculty of Health and Medical Sciences at the University of Surrey to run the RDS South East.

CHSS’ Bridget Carpenter, Business Director for the RDS South East, said: ‘The NIHR RDS makes a vital contribution to our national health and economy. The renewal of this contract means that health and social care researchers in the South East can continue to benefit from the specialist, free support in formulating research proposals. This includes advice on identifying an appropriate funding stream, statistics, health economics, qualitative methodology, and support for patient and public involvement in research.’

Professor Dame Sally C Davies, Chief Medical Officer and Chief Scientific Adviser at the Department of Health, said: ‘The NIHR is transforming research in the NHS to improve the diagnosis, treatment and prevention of disease. It is very important that researchers applying for NIHR funding access the services provided by the RDS so that they can submit their best applications to the NIHR and others for funding.’

Valerie Hall, Director of RDS South East and Professor of Midwifery at the University of Brighton, said: ‘The award is great news. Over the last five years, we have built an excellent team who deliver really effective support. Advice is informed, confidential – and completely free.  The new contract provides an opportunity to carry on working with academics and clinicians to develop high quality research applications that will ultimately benefit patients and improve health.’

RDS South East is one of a national network of ten NIHR RDS centres in England.

CHSS is a research unit within Kent’s School of Social Policy, Sociology and Social Research (SSPSSR).

Posted in news | Leave a comment

Medway School of Pharmacy shortlisted for national training award

Medway School of Pharmacy has been shortlisted for a prestigious Training Provider of the Year award by a national science skills council.

The shortlisting – by Cogent, the Sector Skills Council (SSC) for the Chemicals, Pharmaceuticals, Nuclear, Life Sciences, Petroleum and Polymer Industries – is for the School’s unique three-year Foundation Degree (Fd Sc) in Applied Bioscience Technology.

The UK Life Sciences Skills Awards will be announced at an event in May being opened by David Willetts MP, the Minister for Universities and Science.

Dr Scott Wildman, Senior Lecturer in Biological Sciences at the Medway School of Pharmacy, said: ‘We are delighted to have been shortlisted for this prestigious award.

‘Our foundation degree is unique in that it provides a very flexible work-based, e-learning experience for individuals employed in bioscience-related industries which can stand alone, or be incorporated into a higher apprenticeship.’

Cogent is licensed by the government to help employers in science-using industries address workforce development needs.

Posted in news | Leave a comment

Update – 28th March 2013

Last week I said that I would update you following the March meeting of the AHSN Transition Board discussion. Attendees came from Kent, Surrey and Sussex representing the NHS, Local Government, Industry and Higher Education Institutions.

Tom Quinn updated the Board on the Collaboration for Leadership in Applied Health Research and Care. A very useful bid preparation session was held last week, attended by around fifty people.

The Board was briefed on the current delivery projects including intraoperative fluid management and the collaborative procurement scoping project. On procurement the outcome of the DH review of NHS Procurement is awaited and on intellectual property (n.b. AHSNs are expected to become centres of excellence on intellectual property) we start to map existing capability within HEIs and beyond. We also discussed the evolving Dementia programme and the draft membership agreement, which Board members reporting back that it was fit for purpose and they fed in minor changes.

The Board noted that the call for early financial pledges to supplement existing resources was likely to enable the AHSN establishment work and Enhancing Quality & Recovery programmes to continue into the new financial year. This has now been confirmed and from next week the AHSN and its staff will be hosted within Royal Surrey County Hospital NHS Foundation Trust.

Although I am living and breathing the AHSN, I recognise it is not the only change taking place in the Health & Social Care landscape! The diagram below sets out the range of statutory bodies that will exist from 1 April.

Kind regards

Guy Boersma
Managing Director (interim)
Kent, Surrey & Sussex Academic Health Science Network

Making integrated care happen at scale and pace

The King’s Fund has published a paper on integrated care. Click here for more details.

Harnessing innovation in the NHS – 19 June 2013, The King’s Fund, London

This conference will explore how to foster innovation in health care, and specifically how the concept of disruptive innovation can benefit the NHS. A disruptive innovation is an innovation that transforms an existing service by introducing simplicity, affordability, convenience and accessibility, where before the service was complicated, expensive and inaccessible.Click here for more information.

 

Posted in ahsn | Leave a comment

Medway School of Pharmacy shortlisted for national training award

Medway School of Pharmacy, which is jointly run by the universities of Kent and Greenwich, has been shortlisted for a prestigious Training Provider of the Year award by a national science skills council.

The shortlisting – by Cogent, the Sector Skills Council (SSC) for the Chemicals, Pharmaceuticals, Nuclear, Life Sciences, Petroleum and Polymer Industries – is for the School’s unique three-year Foundation Degree (Fd Sc) in Applied Bioscience Technology.

The UK Life Sciences Skills Awards will be announced at an event in May being opened by David Willetts MP, the Minister for Universities and Science.

Dr Scott Wildman, Senior Lecturer in Biological Sciences at the Medway School of Pharmacy, said: ‘We are delighted to have been shortlisted for this prestigious award.

‘Our foundation degree is unique in that it provides a very flexible work-based, e-learning experience for individuals employed in bioscience-related industries which can stand alone, or be incorporated into a higher apprenticeship.’

Cogent is licensed by the government to help employers in science-using industries address workforce development needs.

Posted in Uncategorized | Leave a comment

KSS AHSN membership

Across the country, AHSN member organisations are being approached this month to formalise their membership. Members are being asked to pledge a financial sum and contribute to the development of a vibrant, member-based network. The draft commitments from members include: undertaking to share data, raising the profile of research performance and uptake of NICE guidance, nominating an AHSN lead in each organisation and communicating with frontline staff about Innovation, Health & Wealth. To support this engagement, we have produced this short guide to the network’s plans and priorities.

Kent Surrey and Sussex Collaboration for Leadership in Applied Health Research and Care application – update from Prof Tom Quinn

A small group with representatives from across KSS is continuing to develop proposals for the Collaboration for Leadership in Applied Health Research and Care (CLAHRC) application. I am delighted that Professor Sube Banerjee has agreed to act as Director, bringing world-class experience in applied clinical research and leadership to the team. Tanya Telling has also joined the team to provide support.

We are getting into the detail of what our proposed CLAHRC might look like, with several ‘candidate themes’ identified by a small working group, and the stocktake of applied health research is nearing completion.
Colleagues who wish to propose a theme or discuss any aspect of the CLAHRC bid are encouraged to contact Tom QuinnSube Banerjee or Tanya Telling.

We are also in the process of developing our PPI and governance arrangements, and organisational CEOs and Vice Chancellors have been asked to consider the issue of matched funding. More detail will be presented and discussed at the workshop on 19 March at Holiday Inn Gatwick – places are still available, please contact Anne Hrassnigg – we are very keen to ensure that the KSS community ‘own’ our proposals!

KSS AHSN establishment update

David Clayton-Smith is the new Chair Designate of Kent Surrey Sussex Academic Health Science Network. David is currently chair at NHS Surrey and at NHS Sussex and has more than 28 years experience gained from working at board level in a number of major companies. His extensive commercial experience includes both executive and non-executive roles including those for Boots The Chemists Ltd, handbag.com and most recently as Chair of The Fairtrade Foundation Ltd.

David Clayton-Smith said: “I hope by matching my private sector skills together with my NHS experience in Surrey and Sussex will make a real difference to the KSS AHSN. I am truly excited by the potential of the network to unleash improvements for both patients and to the local economies and look forward to meeting and working with our partners from April.”

I would like to take this opportunity to thank Adrian Bull, our Interim Chair, for his time, energy and personal support. Starting any new enterprise is no small task and KSS ASHN now undertaking project work for members in its own right reflects Adrian’s vision and motivation to realise our shared ambition. I’m sure you will join me in wishing him every success at the Imperial College Health Partners AHSN.

Kind regards

Guy Boersma
Managing Director (interim)
Kent, Surrey & Sussex Academic Health Science Network

News

Telecare may not cut costs, but it could have other benefits for patients, says Adam Steventon, lead researcher on the DH’s Whole Systems Demonstrator trial

There’s been growing interest in the potential of telecare to help frail people maintain their independence at home. Though telecare can take many forms, since the Department of Health’s Building Telecare in England report, the number of pendant alarms in England has increased to around 1.5 million. And some local authorities are beginning to invest in newer forms of telecare like automatic falls and bed occupancy sensors.

Some advocates have claimed that telecare can deliver benefits for older people and their carers while reducing costs – the latter happening through reductions in admissions to care homes and hospitals, as well as a shortening of length of stay in hospital (through facilitating faster discharge to a safer place in the community). Evidence about the effect of telecare on use of care services, however, has been scarce, with several systematic reviews concluding that no high-quality studies exist.

As social care budgets become more and more strained, the need for robust evidence will increase. If telecare is cost effective, then increased adoption might be an efficient route to providing better services at lower overall costs. But if telecare is not cost effective, then the money might be better spent elsewhere – for example, being a bit less restrictive with eligibility for domiciliary care.

In recognition of the need for evidence, in 2006 the Department of Health announced three large ‘Whole Systems Demonstrator’ sites in Cornwall, Kent and Newham in England. This provided the opportunity for a large, randomised controlled trial of telecare, with 2,600 participants. We believe it is the largest such trial undertaken.

Click here for more.

 

First round of successful applications for dementia fund

The Department of Health has announced the successful applicants for stage 1 of the £50m funding of capital projects to improve care environments for people with dementia. Click here for details.

 

The National Institute for Health Research Clinical Research

The National Institute for Health Research Clinical Research Network has produced a resource pack to help NHS trusts raise awareness of clinical research among patients and carers, and deliver on the NHS Constitution commitment to provide research information supporting patient choice. Click here for details.

Posted in ahsn | Leave a comment

Research seminars

Seminar programme

Seminars are held at 4.00 p.m. on Mondays in Biosciences Lecture Theatre 1 unless otherwise stated. If you would like to meet the speaker during his/her visit please contact the host.

Monday 11th March [1] Professor Franz Rödel
– Department of Radiotherapy and Oncology, University Hospital of Frankfurt, Johann Wolfgang-Goethe Universität Frankfurt am Main, Germany

The Inhibitor of Apoptosis Protein (IAP) Survivin as a prognostic/predictive marker and molecular target in cancer therapy.

Host: Professor Martin Michaelis [2]

Monday 18th March [3] Dr. Jason Schnell
– Department of Biochemistry, University of Oxford

Structural studies of the twin-arginine transclocase pore.

Host: Dr. Jeremy Rossman [4]

Monday 25th March [5] Professor Kingston Mills
– School of Biochemistry and Immunology, Trinity College Dublin

New immunotherapeutic approaches for autoimmunity and cancer.

Host: Professor Martin Warren [6]

Posted in events | Leave a comment

SHREWD: the Single Health Resilience Early Warning Database

In November 2012, the Centre for Health Services Studies at the University of Kent was commissioned by NHS Kent and Medway to conduct a rapid (23 day) appraisal of the SHREWD system and the way it was currently operating across Kent and Medway. SHREWD – Single Health Resilience Early Warning Database – is an “online, real-time early warning and decision support tool”, developed by Transforming Systems (a human systems focused software development company) in collaboration with NHS Kent and Medway, partners within the Medway health system, and the University of Greenwich, with financial support from the South East Coast Strategic Health Authority. It is a system designed to be accessed and updated by partners within a local health system in order to share ‘system critical’ information.

Download the document in PDF format.

Posted in news | Leave a comment

Tizard Centre Taster Sessions 2013

Come and experience what it is like to study at the Tizard Centre and hopefully learning something new at the same time. These sessions provide free training but also give you the chance to find out more about studying at the Tizard Centre.  Our sessions run from 0930-1300hrs and are held at the Kent Business School, University of Kent, Canterbury campus.

Thank you for such a great lecture, I wish I had heard it before working with challenging behaviour but I feel I learned so much from you”
Georgina Zucchini-Watts, L’Arche, 2012.

Wednesday 24th April 2013 – Tony Osgood, Lecturer in Learning Disability

“Learning To Listen: Partnership & Person Centred Support in Challenging Behaviour

The morning will detail person centred approaches to supporting people whose behaviour challenges the competencies of service systems, and participants will leave with some approaches shown to be effective. 

Tuesday 21st May 2013 – Peter McGill, Co-Director and Reader in the Applied Psychology of Learning DisabilityChallenging behaviour and positive behaviour support.

This session will address three questions:

  • why do people behave in challenging ways?
  • what is positive behaviour support?
  • practical approaches to managing behaviour.

The intention is to give participants a taste of the academic and practical issues surrounding challenging behaviour which is covered in much more depth on our courses. 

Wednesday 12th June 2012 – Julie Beadle-Brown, Reader in Intellectual and Developmental Disabilities

“Skilled support for people with Autism” 

After these sessions there will be an opportunity to speak to some members of the Tizard team. If you wish to sign up for these please email J.Ruffels@kent.ac.uk

Posted in news | Leave a comment

Important discovery about one of the pigments of life

Researchers at the University of Kent have discovered a new way in which nature makes heme – the component that gives blood its colour and allows red blood cells to carry oxygen around the body.

Until now it was not known that heme, one of the key pigments of life, can be made from a related molecule called siroheme by some very unusual and unexpected chemical processes – a discovery that principal investigator Professor Martin Warren has described as being similar in importance and scale to the ‘transformation of the first electronic calculators into the modern mobile phone’.

Heme performs many roles in the biology of a very large number of organisms. It is perhaps more well-known for the role it performs when it is found attached to the large protein globin – together called haemoglobin. Molecules attached to proteins in such a way that allows them to perform a role are known as ‘prosthetic groups’. Both the protein and the prosthetic group have to be synthesised from basic building blocks and then stuck together – all via various chemical processes in human cells.

In a Biotechnology and Biological Sciences Research Council (BBSRC) funded collaboration with the University of Oxford and Portugal’s Instituto de Tecnologia Química e Biológica (ITQB), the team from Kent’s School of Biosciences studied the process by which heme is synthesised in Archaea (a unique type of single-celled organism). Using state-of-the-art anaerobic facilities on Kent’s Canterbury campus, they showed at a molecular level that, within Archea, siroheme is hijacked and brought into the chemical process that synthesises heme. In molecular and cellular biochemistry this is a very rare example where one prosthetic group is cannibalised for the synthesis of another.

The project involved studying a number of very unusual biochemical reactions in glove-boxes that are completely devoid of oxygen. It was only under these unique conditions that the researchers were able to observe the reactions taking place.

Professor Warren, who is Head of the School of Biosciences at Kent, said: ‘This is a very important piece of basic science that offers an explanation as to how biochemical pathways evolve and become more complex. Moreover, we have learnt some new concepts about how chemistry can be used to change the shape and the character of larger molecules, which can then be applied for the development of new compounds; for instance, in the pharmaceutical industry or the production of biofuels. In this respect our research contributes to the field of synthetic biology.’

Professor Warren also explained that the new nuclear magnetic resonance (NMR) spectroscopy machine within his School was invaluable during the process. ‘The extra sensitivity of this machine allowed the structure of new intermediates on the pathway to be determined,’ he said.

‘Molecular hijacking of siroheme for the synthesis of heme and d1 heme’ (Shilpa Bali, Andrew D. Lawrence, Susana A. Lobo, Lígia M. Saraiva, Bernard T. Golding, David J. Palmer, Mark J. Howard, Stuart J. Ferguson and Martin J. Warren) was published by Proceedings of the National Academy of Sciences of the United States of America (PNAS), the official journal of the United States National Academy of Sciences, on 3 October.

Posted in news | Leave a comment

Transition Board update

We hope you to see you at Expo on 13/14 March where we have a stand, are speaking about improving outcomes and reducing variation and plan to spend some time in the dementia ” village ” building on our local knowledge from Crawley CCG and others of what can be done to create a dementia friendly community. The EXPO programme can be found on the Healthcare Innovation Expo website.

This is a key month in terms of AHSN establishment actions. Nationally, Sir David Nicholson and Dame Sally Davies make their decision on whether the 15 proposed AHSNs are licensed in one or more tranches.

Locally we appoint an Independent Chair, migrate equipment, leases and third party licenses to our host organisation and start work on the option appraisal for our future organisational form. Options include hosting within a Higher Education Institute, an NHS Foundation Trust and becoming an incorporated company limited by guarantee.

With this context in their mind the Transition Board met last week. Key points to note from the discussion are:

– the risks to delivery of the Enhancing Quality & Recovery programme

– that job descriptions will be prepared so we can offer our first secondment opportunities to staff from member organisations

– that members will be approached for initial membership contributions

– plans to invest time released from establishment activity, in member engagement through holding our first Partnership Board day in May, introducing county- based events and a monthly newsletter, setting up a website and holding dementia collaborative events.

We also had a discussion on Dementia to help shape our Dementia work programme. We agreed that members weren’t looking for a “meta programme to sit above existing projects and programmes” but that we should develop a programme of work with a focus on using our scale and reach and facilitate effective interaction and responses between industry, health and social care.

Posted in ahsn | Leave a comment